A population-based cohort study on chronic obstructive pulmonary disease in Latin America: Methods and preliminary results: The PLATINO study phase II;Estudio de cohorte de base poblacional sobre la enfermedad pulmonar obstructiva crónica en Latinoamérica: Métodos y resultados preliminares: Fase II del estudio PLATINO

Archivos de Bronconeumologia

Volumn 50, Issue 1, 2014, Pages 10-17

  Menezes, Ana Maria Baptista ^a   Muiño, Adriana ^b   López Varela, Maria Victorina ^c   Valdivia, Gonzalo ^d   Lisboa, Carmen ^d   Jardim, José Roberto ^e   Montes de Oca, Maria ^f   Tálamo, Carlos ^f   Wehrmeister, Fernando César ^a   Perez Padilla, Rogelio ^g  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b Centro Hospitalario Pereira Rossell   (Uruguay)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^g INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Chronic obstructive pulmonary disease; Latin America; Longitudinal studies

Indexed keywords

ARTICLE; BRAZIL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DEATH CERTIFICATE; DISEASE COURSE; EDUCATIONAL STATUS; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MEXICO; MORTALITY; POPULATION RESEARCH; SPIROMETRY; SURVIVAL RATE; ADULT; BRAZILIAN; CHILEAN; FEMALE; MALE; MIDDLE AGED; SMOKING; URUGUAYAN;

EID: 84892486624     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2013.12.006     Document Type: Article

References (33)

1. PLATINO - Proyecto Latinoamericano de Investigación en Obstrucción Pulmonar [consultado 25 Nov 2012]. Disponible en: http://www.platino-alat.org/.
2. Burrows B. An overview of obstructive lung diseases. Med Clin North Am 1981, 65:455-471.
3. Vestbo J., Hurd S.S., Agusti A.G., Jones P.W., Vogelmeier C., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
4. Menezes A.M., Perez-Padilla R., Jardim J.R., Muino A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881.
5. Menezes A.M., Victora C.G., Perez-Padilla R. The PLATINO project: Methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 2004, 4:15.
6. Castaldi P.J., Cho M.H., Litonjua A.A., Bakke P., Gulsvik A., Lomas D.A., et al. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol 2011, 45:1147-1153.
7. Celli B.R., Locantore N., Yates J., Tal-Singer R., Miller B.E., Bakke P., et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 185:1065-1072.
8. Qiu W., Baccarelli A., Carey V.J., Boutaoui N., Bacherman H., Klanderman B., et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 2012, 185:373-381.
9. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
10. Agusti A., Edwards L.D., Rennard S.I., MacNee W., Tal-Singer R., Miller B.E., et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One 2012, 7:e37483.
11. Pinto-Plata V., Casanova C., Mullerova H., de Torres J.P., Corado H., Varo N., et al. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD. Respir Res 2012, 13:71.
12. Ferris B.G. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978, 118:1-120.
13. Ware J.E., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220.
14. Fagerstrom K.O., Schneider N.G. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989, 12:159-182.
15. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
16. Bonilla J., Bernal G., Santos A., Santos D. A revised Spanish version of the Beck Depression Inventory: Psychometric properties with a Puerto Rican sample of college students. J Clin Psychol 2004, 60:119-130.
17. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
18. Perez-Padilla R., Vazquez-Garcia J.C., Marquez M.N., Menezes A.M. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2008, 53:1019-1026.
19. Lohman T.G., Roche A.F., Martorell R. Anthropometric Standardization Reference Manual 1988, Human Kinetics Books, Champaign, IL.
20. Habicht J.P. Standardization of quantitative epidemiological methods in the field. Bol Oficina Sanit Panam 1974, 76:375-384.
21. EpiData software [consultado 10 Nov 2012]. Disponible en: http://www.epidata.dk/.
22. Stata: data analysis and statistical software [consultado 21 Nov 2012]. Disponible en: http://www.stata.com/.
23. Kaufman L., Rousseeuw P.J. Finding Groups in Data: An Introduction to Cluster Analysis 1990, Wiley Online Library.
24. Agusti A., Calverley P.M., Celli B., Coxson H.O., Edwards L.D., Lomas D.A., et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11:122.
25. Jenkins C.R., Jones P.W., Calverley P.M., Celli B., Anderson J.A., Ferguson G.T., et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009, 10:59.
26. Tashkin D.P., Celli B., Senn S., Burkhart D., Kesten S., Menjoge S., et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
27. Soriano J.B., Ancochea J., Miravitlles M., Garcia-Rio F., Duran-Tauleria E., Munoz L., et al. Recent trends in COPD prevalence in Spain: A repeated cross-sectional survey 1997-2007. Eur Respir J 2010, 36:758-765.
28. Kirkwood B.R., Sterne J.A.C. Survival analysis: Displaying and comparing survival patterns. Essential Medical Statistics 2003, 272-286. Blackwell Science, Oxford. 2nd ed. B.R. Kirkwood, J.A.C. Sterne (Eds.).
29. Elliott P., Peakman T.C. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 2008, 37:234-244.
30. Holland N.T., Smith M.T., Eskenazi B., Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003, 543:217-234.
31. AbouZahr C., Cleland J., Coullare F., Macfarlane S.B., Notzon F.C., Setel P., et al. The way forward. Lancet 2007, 370:1791-1799.
32. Laurenti R., de Mello Jorge M.H., Gotlieb S.L. Underlying cause-of-death mortality statistics: Considering the reliability of data. Rev Panam Salud Publica 2008, 23:349-356.
33. Florindo A.A., Latorre M.do R., Jaime P.C., Tanaka T., Zerbini C.A. Methodology to evaluation the habitual physical activity in men aged 50 years or more. Rev Saude Publica 2004, 38:307-314.